Last reviewed · How we verify
PCSK9 Antibody, PCSK9 Enzyme
PCSK9 Antibody, PCSK9 Enzyme is a Small molecule drug developed by LifeBridge Health. It is currently in Phase 2 development.
At a glance
| Generic name | PCSK9 Antibody, PCSK9 Enzyme |
|---|---|
| Sponsor | LifeBridge Health |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) (PHASE3)
- COAST Study - Cholesterol Optimization After Stroke
- In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme
- Lipid Management in Renal Transplant Recipients Using Evolocumab. (PHASE4)
- Bococizumab HIV Evaluation (B-HIVE) Study (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PCSK9 Antibody, PCSK9 Enzyme CI brief — competitive landscape report
- PCSK9 Antibody, PCSK9 Enzyme updates RSS · CI watch RSS
- LifeBridge Health portfolio CI
Frequently asked questions about PCSK9 Antibody, PCSK9 Enzyme
What is PCSK9 Antibody, PCSK9 Enzyme?
PCSK9 Antibody, PCSK9 Enzyme is a Small molecule drug developed by LifeBridge Health.
Who makes PCSK9 Antibody, PCSK9 Enzyme?
PCSK9 Antibody, PCSK9 Enzyme is developed by LifeBridge Health (see full LifeBridge Health pipeline at /company/lifebridge-health).
What development phase is PCSK9 Antibody, PCSK9 Enzyme in?
PCSK9 Antibody, PCSK9 Enzyme is in Phase 2.
Related
- Manufacturer: LifeBridge Health — full pipeline
- Compare: PCSK9 Antibody, PCSK9 Enzyme vs similar drugs
- Pricing: PCSK9 Antibody, PCSK9 Enzyme cost, discount & access